Figure 5From: Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma ROC curves used to predict performance of soluble CD147 for distinguishing HCC from healthy controls. (A) ROC curve evaluating those with HCC (n = 62) and healthy controls (n = 25). (B) ROC curve evaluating those with AFP-negative HCC (n = 33) and healthy controls (n = 25). (C) ROC curve evaluating those with early stage HCC (n = 31) and healthy controls (n = 25). (D) ROC curve evaluating those with very early stage HCC (n = 12) and healthy controls (n = 25).Back to article page